Connect Biopharma Holdings CNTB
NASDAQ CNTB
$0.75 -0.05 (-6.32%)
As of: Oct 22, 2026 · 3:52 PM EDT

Connect Biopharma Holdings (CNTB) Long-Term Investments (2022)

Updated

Connect Biopharma Holdings (CNTB) posted Long-Term Investments of $9.24 million for Q4 2022.

Analysis

Connect Biopharma Holdings (CNTB) Long-Term Investments (2022) Analysis & Trends

At the end of FY2022, Connect Biopharma Holdings' Long-Term Investments came in at $9.44 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,168.43 Bn 1,137.01 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 647.59 Bn 567.45 Bn 17.30 Bn -
3 AbbVie 503.21 Bn 476.32 Bn 12.70 Bn 266.00 Mn
4 Merck 366.30 Bn 320.68 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 303.04 Bn 267.03 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 267.68 Bn 241.37 Bn 12.86 Bn 297.00 Mn
7 Amgen 242.11 Bn 197.51 Bn 7.24 Bn -
8 Gilead Sciences 194.85 Bn 169.05 Bn 6.22 Bn -
9 Pfizer 173.11 Bn 119.75 Bn 10.94 Bn 1.56 Bn
10 Connect Biopharma Holdings 46.74 Mn -129.93 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 9.44 Mn
Jun 30, 2022 22.30 Mn
API Access

Connect Biopharma Holdings Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=CNTB&period=max&api_key=YOUR_API_KEY